13.07.2015 Views

Pain Management in Cancer Patients: A Review - Pakistan ...

Pain Management in Cancer Patients: A Review - Pakistan ...

Pain Management in Cancer Patients: A Review - Pakistan ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

292 Wasam Liaqat Tarar et alpa<strong>in</strong>-reliev<strong>in</strong>g procedures. Both cancer therapy andtherapy can h<strong>in</strong>der pa<strong>in</strong> therapy by exacerbat<strong>in</strong>gpa<strong>in</strong> or implicat<strong>in</strong>g other adverse effects. On theother hand it can be of help to pa<strong>in</strong> therapy byreduc<strong>in</strong>g the proliferation of cancer, lend<strong>in</strong>g handas co-analgesic, and by provid<strong>in</strong>g route for IVadm<strong>in</strong>istration of drugs accord<strong>in</strong>g to patients needs.Likewise pa<strong>in</strong> therapy can improve cancer therapyby the performance status of patient and surgicallyperformed <strong>in</strong>terventions can help improve organfunction [18].3.6. Use of Multiple OpioidsNo s<strong>in</strong>gle opioid is completely safe. As drugs areonly tools, it depends on our expertise how we usethem to get the desired therapeutic outcomes. Doseescalation with many co-adm<strong>in</strong>istered opioids leadsto adequate pa<strong>in</strong> relief along with many unwantedside effects <strong>in</strong> cancer patients with pa<strong>in</strong>. Drugswitch<strong>in</strong>g from one opioid to another is found to behelpful with no considerable correlation among thegenetics and opioid response [19].3.7. Morph<strong>in</strong>e vs. OxycodoneWhen <strong>in</strong>travenous dos<strong>in</strong>g of two drugs i.e., morph<strong>in</strong>eand oxycodone is compared, it is found that equalanalgesic effect is achieved from both drugs. Theirbioavailability is pretty much similar, only a littlehigher for oxycodone hydrochloride. The patientsIV dose for oxycodone hydrochloride to producesame amount of analgesia as morph<strong>in</strong>e is 30%higher. Nausea and halluc<strong>in</strong>ations are the drawbacksof morph<strong>in</strong>e use. Otherwise both morph<strong>in</strong>e andoxycodone are similar <strong>in</strong> their actions and there is [20].3.8. Sp<strong>in</strong>al Adm<strong>in</strong>istration of OpioidsThe sp<strong>in</strong>al adm<strong>in</strong>istration of opioids may provideanalgesia for longer duration to patients suffer<strong>in</strong>gfrom bilateral or midl<strong>in</strong>e lower abdom<strong>in</strong>al or pelviccancer pa<strong>in</strong>. However, there are certa<strong>in</strong> reasonswhich make the use of sp<strong>in</strong>ally adm<strong>in</strong>isteredanalgesics obscure. Cross-tolerance to orallyand parenterally adm<strong>in</strong>istered narcotics is of to sp<strong>in</strong>al narcotics has also markedly limited theirusefulness. Opioids extensively distribute <strong>in</strong> theCSF and plasma when adm<strong>in</strong>istered through theepidural or <strong>in</strong>trathecal route. The drug reach<strong>in</strong>g tobra<strong>in</strong> stem sites may account for many of the toxicand therapeutic effects of sp<strong>in</strong>al opioids [21].3.9. Use of Benzodiazep<strong>in</strong>esBenzodiazep<strong>in</strong>es can be used to <strong>in</strong>directly managecancer pa<strong>in</strong> and have been found effective. It isrelated to their psychotropic effects <strong>in</strong>clud<strong>in</strong>greduction of anxiety and depression <strong>in</strong> many<strong>in</strong>stances. Benzodiazep<strong>in</strong>es can serve the purposefor treat<strong>in</strong>g chronic pa<strong>in</strong>, acute muscle spasm andassociated anxiety, and neuropathic pa<strong>in</strong>. Alprazolamand clonazepam have been found to be drugs ofchoice. They should not be always considered as with potential harmful effects sometimes such asphysical and psychological dependence, cognitiveimpairment, worsen<strong>in</strong>g depression, overdose, andmany other side effects [22].4. BARRIERS TO CANCER PAINMANAGEMENTThe various obstacles <strong>in</strong>clud<strong>in</strong>g behaviours whichprevent successful management of pa<strong>in</strong> are referredfear of addiction and tolerance of analgesics, poorassessment of pa<strong>in</strong>, communication barrier amonghealthcare professionals and patients and somereligious and cultural norms which all cumulativelylead to poor pa<strong>in</strong> control. [23] [24] Reluctance ofpatients to report pa<strong>in</strong> and utilization of analgesicsstand at the top of the list. The patients are concernedabout the addiction caus<strong>in</strong>g factor of analgesicsand their side effects. There is also a wrong notion<strong>in</strong> patient’s m<strong>in</strong>ds that pa<strong>in</strong> is part and parcel ofcancer and ‘good patients do not wh<strong>in</strong>e about pa<strong>in</strong>’.It should be eradicated from patient’s m<strong>in</strong>ds. A educated and patients belong<strong>in</strong>g to lower <strong>in</strong>comegroup have these sorts of concerns. Higher pa<strong>in</strong><strong>in</strong>tensity and under treatment of pa<strong>in</strong> leads to moreconcerns. [25] Other barriers <strong>in</strong>cluded <strong>in</strong> effectivepa<strong>in</strong> management are poor assessment of pa<strong>in</strong>,physicians are reluctant to prescribe opioids andperceived excessive regulation. The barriers and

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!